Works matching AU Scott, Clare

Results: 85
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.

    Published in:
    Cells (2073-4409), 2019, v. 8, n. 3, p. 200, doi. 10.3390/cells8030200
    By:
    • Bagnoli, Marina;
    • Shi, Ting Yan;
    • Gourley, Charlie;
    • Speiser, Paul;
    • Reuss, Alexander;
    • Nijman, Hans W.;
    • Creutzberg, Carien L.;
    • Scholl, Suzy;
    • Negrouk, Anastassia;
    • Brady, Mark F.;
    • Hasegawa, Kosei;
    • Oda, Katsutoshi;
    • McNeish, Iain A.;
    • Kohn, Elise C.;
    • Oza, Amit M.;
    • MacKay, Helen;
    • Millan, David;
    • Bennett, Katherine;
    • Scott, Clare;
    • Mezzanzanica, Delia
    Publication type:
    Article
    10
    11
    12
    13
    14

    Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

    Published in:
    2016
    By:
    • Matulonis, Ursula A.;
    • Harter, Philipp;
    • Gourley, Charlie;
    • Friedlander, Michael;
    • Vergote, Ignace;
    • Rustin, Gordon;
    • Scott, Clare;
    • Meier, Werner;
    • Shapira‐Frommer, Ronnie;
    • Safra, Tamar;
    • Matei, Daniela;
    • Fielding, Anitra;
    • Spencer, Stuart;
    • Parry, David;
    • Grinsted, Lynda;
    • Ledermann, Jonathan A.;
    • Shapira-Frommer, Ronnie
    Publication type:
    journal article
    15
    16
    17
    18
    19

    Farletuzumab ecteribulin and MORAb‐109, folate receptor alpha and mesothelin targeting antibody–drug conjugates, show activity in poor prognosis gynaecological cancer models.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 3, p. 1, doi. 10.1002/ctm2.70274
    By:
    • Nesic, Ksenija;
    • Rybinski, Katherine;
    • Ratnayake, Gayanie;
    • Ho, Gwo‐Yaw;
    • Lim, Ratana;
    • Radke, Marc;
    • Neagle, Chloe;
    • Swisher, Elizabeth M.;
    • Wakefield, Matthew J.;
    • Barker, Holly E.;
    • Furuuchi, Keiji;
    • Scott, Clare L.;
    • Vandenberg, Cassandra J.
    Publication type:
    Article
    20
    21

    Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-OV80).

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e51
    By:
    • Jung-Yun Lee;
    • Tan, David;
    • Ray-Coquard, Isabelle;
    • Jung Bok Lee;
    • Byoung Gie Kim;
    • Van Nieuwenhuysen, Els;
    • Yun-Ju Huang, Ruby;
    • Ka Yu Tse;
    • González-Martin, Antonio;
    • Scott, Clare;
    • Hasegawa, Kosei;
    • Wilkinson, Katie;
    • Eun Yeong Yang;
    • Lheureux, Stephanie;
    • Kristeleit, Rebecca
    Publication type:
    Article
    22
    23
    24
    25
    26

    RESPONSE.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 12, p. 952
    By:
    • Chenevix-Trench, Georgia;
    • Dörk, Thilo;
    • Scott, Clare;
    • Hopper, John
    Publication type:
    Article
    27

    Dominant negative ATM mutations in breast cancer families.

    Published in:
    2002
    By:
    • Chenevix-Trench, Georgia;
    • Spurdle, Amanda B;
    • Gatei, Magtouf;
    • Kelly, Helena;
    • Marsh, Anna;
    • Chen, Xiaoqing;
    • Donn, Karen;
    • Cummings, Margaret;
    • Nyholt, Dale;
    • Jenkins, Mark A;
    • Scott, Clare;
    • Pupo, Gulietta M;
    • Dörk, Thilo;
    • Bendix, Regina;
    • Kirk, Judy;
    • Tucker, Katherine;
    • McCredie, Margaret R E;
    • Hopper, John L;
    • Sambrook, Joseph;
    • Mann, Graham J
    Publication type:
    journal article
    28

    Dominant Negative ATM Mutations in Breast Cancer Families.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 3, p. 205, doi. 10.1093/jnci/94.3.205
    By:
    • Chenivix-Trench, Georgia;
    • Spurdle, Amanda B.;
    • Gatei, Magtouf;
    • Kelly, Helena;
    • Marsh, Anna;
    • Xiaoqing Chen;
    • Donn, Karen;
    • Cummings, Margaret;
    • Nyholt, Dale;
    • Jenkins, Mark A.;
    • Scott, Clare;
    • Pupo, Gulietta M.;
    • Dörk, Thilo;
    • Bendix, Regina;
    • Kirk, Judy;
    • Tucker, Katherine;
    • McCredie, Margaret R.E.;
    • Hopper, John L.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysis.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 14, p. 2432, doi. 10.1002/cncr.33517
    By:
    • Lee, Chee Khoon;
    • Friedlander, Michael L.;
    • Tjokrowidjaja, Angelina;
    • Ledermann, Jonathan A.;
    • Coleman, Robert L.;
    • Mirza, Mansoor R.;
    • Matulonis, Ursula A.;
    • Pujade‐Lauraine, Eric;
    • Bloomfield, Ralph;
    • Goble, Sandra;
    • Wang, Ping;
    • Glasspool, Rosalind M.;
    • Scott, Clare L.
    Publication type:
    Article
    42
    43
    44
    45
    46

    ABCC4/MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 8, p. 2225, doi. 10.1002/ijc.33005
    By:
    • Jung, Moonsun;
    • Gao, Jixuan;
    • Cheung, Leanna;
    • Bongers, Angelika;
    • Somers, Klaartje;
    • Clifton, Molly;
    • Ramsay, Emma E.;
    • Russell, Amanda J.;
    • Valli, Emanuele;
    • Gifford, Andrew J.;
    • George, Joshy;
    • Kennedy, Catherine J.;
    • Wakefield, Matthew J.;
    • Topp, Monique;
    • Ho, Gwo‐Yaw;
    • Scott, Clare L.;
    • Bowtell, David D.;
    • deFazio, Anna;
    • Norris, Murray D.;
    • Haber, Michelle
    Publication type:
    Article
    47

    Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.

    Published in:
    EMBO Molecular Medicine, 2021, v. 13, n. 5, p. 1, doi. 10.15252/emmm.202013366
    By:
    • Hoppe, Michal M;
    • Jaynes, Patrick;
    • Wardyn, Joanna D;
    • Upadhyayula, Sai Srinivas;
    • Tan, Tuan Zea;
    • Lie, Stefanus;
    • Lim, Diana G Z;
    • Pang, Brendan N K;
    • Lim, Sherlly;
    • P S Yeong, Joe;
    • Karnezis, Anthony;
    • Chiu, Derek S;
    • Leung, Samuel;
    • Huntsman, David G;
    • Sedukhina, Anna S;
    • Sato, Ko;
    • Topp, Monique D;
    • Scott, Clare L;
    • Choi, Hyungwon;
    • Patel, Naina R
    Publication type:
    Article
    48

    Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.

    Published in:
    Australian & New Zealand Journal of Obstetrics & Gynaecology, 2024, v. 64, n. 4, p. 319, doi. 10.1111/ajo.13792
    By:
    • Rajadevan, Niveditha;
    • Flinkier, Ariane;
    • Saunders, Hugo;
    • Lee, Yeh Chen;
    • Scott, Clare;
    • Khaw, Pearly;
    • Allan, Prue;
    • Davies, Claire;
    • Andrews, John;
    • Wilson, Michelle;
    • Lombard, Janine M;
    • Harrison, Michelle;
    • Nesfield, Heshani;
    • DeFazio, Anna;
    • Meniawy, Tarek;
    • Gorringe, Kylie L
    Publication type:
    Article
    49
    50